BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferrone M, Raimondo M, Scolapio JS. Pancreatic enzyme pharmacotherapy. Pharmacotherapy. 2007;27:910-920. [PMID: 17542772 DOI: 10.1592/phco.27.6.910] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lai X, Tang J, ElSayed MEH. Recent advances in proteolytic stability for peptide, protein, and antibody drug discovery. Expert Opin Drug Discov 2021;:1-16. [PMID: 34187273 DOI: 10.1080/17460441.2021.1942837] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Tóth GD, Kazsoki A, Gyarmati B, Szilágyi A, Vasvári G, Katona G, Szente L, Zelkó R, Poppe L, Balogh-Weiser D, Balogh GT. Nanofibrous Formulation of Cyclodextrin Stabilized Lipases for Efficient Pancreatin Replacement Therapies. Pharmaceutics 2021;13:972. [PMID: 34199011 DOI: 10.3390/pharmaceutics13070972] [Reference Citation Analysis]
3 Haber PS, Kortt NC. Alcohol use disorder and the gut. Addiction 2021;116:658-67. [PMID: 32511812 DOI: 10.1111/add.15147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
4 Williams L, Rhodes KS, Karmally W, Welstead LA, Alexander L, Sutton L. Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span. Journal of Clinical Lipidology 2018;12:908-19. [DOI: 10.1016/j.jacl.2018.04.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
5 Zeng Y, Pu X, Yang J, Du J, Yang X, Li X, Li L, Zhou Y, Yang T. Preventive and Therapeutic Role of Functional Ingredients of Barley Grass for Chronic Diseases in Human Beings. Oxid Med Cell Longev 2018;2018:3232080. [PMID: 29849880 DOI: 10.1155/2018/3232080] [Cited by in Crossref: 22] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
6 Nofal YH, Abu Dail Y, Assaf Y, Abo Samra H, Abbas F, Hamzeh A, Alhaj Hasan N; Cochrane Upper GI and Pancreatic Diseases Group. Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012952] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Peng W, Furuuchi N, Aslanukova L, Huang YH, Brown SZ, Jiang W, Addya S, Vishwakarma V, Peters E, Brody JR, Dixon DA, Sawicki JA. Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 2018;38:e00427-17. [PMID: 29133460 DOI: 10.1128/MCB.00427-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
8 Dallas DC, Sanctuary MR, Qu Y, Khajavi SH, Van Zandt AE, Dyandra M, Frese SA, Barile D, German JB. Personalizing protein nourishment. Crit Rev Food Sci Nutr 2017;57:3313-31. [PMID: 26713355 DOI: 10.1080/10408398.2015.1117412] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
9 Antonini F, Crippa S, Falconi M, Macarri G, Pezzilli R. Pancreatic enzyme replacement therapy after gastric resection: An update. Dig Liver Dis 2018;50:1-5. [PMID: 29170072 DOI: 10.1016/j.dld.2017.10.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
10 Singh VK, Schwarzenberg SJ. Pancreatic insufficiency in Cystic Fibrosis. Journal of Cystic Fibrosis 2017;16:S70-8. [DOI: 10.1016/j.jcf.2017.06.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
11 Bartels RH, Bourdon C, Potani I, Mhango B, van den Brink DA, Mponda JS, Muller Kobold AC, Bandsma RH, Boele van Hensbroek M, Voskuijl WP. Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial. J Pediatr 2017;190:85-92.e2. [PMID: 28912050 DOI: 10.1016/j.jpeds.2017.07.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
12 Brock A, Aldag I, Edskes S, Hartmann M, Herzog T, Uhl W, Schnekenburger J. Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency. Eur J Gastroenterol Hepatol 2016;28:1305-12. [PMID: 27518039 DOI: 10.1097/MEG.0000000000000720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Gelfond D, Heltshe S, Ma C, Rowe SM, Frederick C, Uluer A, Sicilian L, Konstan M, Tullis E, Roach RN, Griffin K, Joseloff E, Borowitz D. Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation. Clin Transl Gastroenterol. 2017;8:e81. [PMID: 28300821 DOI: 10.1038/ctg.2017.10] [Cited by in Crossref: 43] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
14 Schulze A, Breite D, Kim Y, Schmidt M, Thomas I, Went M, Fischer K, Prager A. Bio-Inspired Polymer Membrane Surface Cleaning. Polymers (Basel) 2017;9:E97. [PMID: 30970776 DOI: 10.3390/polym9030097] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
15 Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC Med. 2017;15:29. [PMID: 28183317 DOI: 10.1186/s12916-017-0783-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
16 Bartels RH, Meyer SL, Stehmann TA, Bourdon C, Bandsma RH, Voskuijl WP. Both Exocrine Pancreatic Insufficiency and Signs of Pancreatic Inflammation Are Prevalent in Children with Complicated Severe Acute Malnutrition: An Observational Study. The Journal of Pediatrics 2016;174:165-70. [DOI: 10.1016/j.jpeds.2016.04.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
17 Heubi JE, Schaeffer D, Ahrens RC, Sollo N, Strausbaugh S, Graff G, Jain R, Witte S, Forssmann K. Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial. J Pediatr. 2016;176:156-161.e1. [PMID: 27297209 DOI: 10.1016/j.jpeds.2016.05.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
18 Majumder S, Chari ST. Chronic pancreatitis. The Lancet 2016;387:1957-66. [DOI: 10.1016/s0140-6736(16)00097-0] [Cited by in Crossref: 199] [Cited by in F6Publishing: 198] [Article Influence: 33.2] [Reference Citation Analysis]
19 Doler C, Schweiger M, Zimmermann R, Breinbauer R. Chemical Genetic Approaches for the Investigation of Neutral Lipid Metabolism. ChemBioChem 2016;17:358-77. [DOI: 10.1002/cbic.201500501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Working Party of the Australasian Pancreatic Club. Smith RC, Smith SF, Wilson J, Pearce C, Wray N, Vo R, Chen J, Ooi CY, Oliver M, Katz T, Turner R, Nikfarjam M, Rayner C, Horowitz M, Holtmann G, Talley N, Windsor J, Pirola R, Neale R. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016;16:164-180. [PMID: 26775768 DOI: 10.1016/j.pan.2015.12.006] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
21 Crosby J, Bellin MD, Radosevich DM, Chinnakotla S, Dunn TB, Pruett TL, Freeman ML, Beilman GJ, Schwarzenberg SJ. Gastrointestinal symptoms before and after total pancreatectomy with islet autotransplantation: the role of pancreatic enzyme dosing and adherence. Pancreas 2015;44:453-8. [PMID: 25486528 DOI: 10.1097/MPA.0000000000000266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
22 Gao HJ, Song Q, Lv FQ, Wang S, Wang YR, Luo YK, Mei XG, Tang J. A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study. J Huazhong Univ Sci Technolog Med Sci 2015;35:707-11. [PMID: 26489626 DOI: 10.1007/s11596-015-1494-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Lahouar L, El-Bok S, Achour L. Therapeutic Potential of Young Green Barley Leaves in Prevention and Treatment of Chronic Diseases: An Overview. Am J Chin Med 2015;43:1311-29. [PMID: 26477798 DOI: 10.1142/S0192415X15500743] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
24 D'Haese JG, Ceyhan GO, Demir IE, Layer P, Uhl W, Löhr M, Rychlik R, Pirilis K, Zöllner Y, Gradl B, Foerster D, Möbius J, Henniges F, Friess H. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life. Pancreas 2014;43:834-41. [PMID: 24717829 DOI: 10.1097/MPA.0000000000000131] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
25 Li L, Somerset S. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig Liver Dis 2014;46:865-74. [PMID: 25053610 DOI: 10.1016/j.dld.2014.06.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
26 Heubi JE. Pancreatic enzyme-replacement therapy in CF: considerations for the USA. Expert Review of Respiratory Medicine 2014;2:589-96. [DOI: 10.1586/17476348.2.5.589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Olesen AE, Brokjaer A, Fisher IW, Larsen IM. Pharmacological challenges in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7302-7307 [PMID: 24259961 DOI: 10.3748/wjg.v19.i42.7302] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
28 Engelen MP, Com G, Anderson PJ, Deutz NE. New stable isotope method to measure protein digestibility and response to pancreatic enzyme intake in cystic fibrosis. Clin Nutr 2014;33:1024-32. [PMID: 24268783 DOI: 10.1016/j.clnu.2013.11.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
29 Münch A, Garten L, Bührer C. Protracted maturation of pancreatic-specific elastase 1 excretion in preterm infants of extremely low gestational age. J Pediatr Gastroenterol Nutr 2013;56:532-6. [PMID: 23201702 DOI: 10.1097/MPG.0b013e31827fb091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
30 Konstan MW, Accurso FJ, Nasr SZ, Ahrens RC, Graff GR. Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis. Clin Investig (Lond) 2013;3:723-9. [PMID: 25210613 DOI: 10.4155/cli.13.62] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
31 Brelian D, Tenner S. Diarrhoea due to pancreatic diseases. Best Pract Res Clin Gastroenterol 2012;26:623-31. [PMID: 23384807 DOI: 10.1016/j.bpg.2012.11.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
32 Engelen MP, Com G, Wolfe RR, Deutz NE. Dietary essential amino acids are highly anabolic in pediatric patients with cystic fibrosis. J Cyst Fibros 2013;12:445-53. [PMID: 23357545 DOI: 10.1016/j.jcf.2012.12.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
33 Wang H, Hagedorn J, Svendsen A, Borch K, Otzen DE. Variant of the Thermomyces lanuginosus lipase with improved kinetic stability: a candidate for enzyme replacement therapy. Biophys Chem 2013;172:43-52. [PMID: 23357413 DOI: 10.1016/j.bpc.2012.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
34 Nakajima K, Oshida H, Muneyuki T, Kakei M. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency. Core Evid. 2012;7:77-91. [PMID: 22936895 DOI: 10.2147/ce.s26705] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
35 Gelfond D, Ma C, Semler J, Borowitz D. Intestinal pH and Gastrointestinal Transit Profiles in Cystic Fibrosis Patients Measured by Wireless Motility Capsule. Dig Dis Sci 2013;58:2275-81. [DOI: 10.1007/s10620-012-2209-1] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 9.3] [Reference Citation Analysis]
36 Caras S, Boyd D, Zipfel L, Sander-Struckmeier S. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency. J Pediatr Gastroenterol Nutr 2011;53:634-40. [PMID: 21681115 DOI: 10.1097/MPG.0b013e3182281c38] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
37 Roberts KJ, Sheridan M, Morris-stiff G, Smith AM. Pancreaticopleural fistula: etiology, treatment and long-term follow-up. Hepatobiliary & Pancreatic Diseases International 2012;11:215-9. [DOI: 10.1016/s1499-3872(12)60151-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
38 Toskes PP, Secci A, Thieroff-Ekerdt R; ZENPEP Study Group. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis. Pancreas. 2011;40:376-382. [PMID: 21343835 DOI: 10.1097/mpa.0b013e31820b971c] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
39 Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011;4:55-73. [PMID: 21753892 DOI: 10.2147/ceg.s17634] [Cited by in Crossref: 16] [Cited by in F6Publishing: 42] [Article Influence: 1.5] [Reference Citation Analysis]
40 Mannion C, Page S, Bell LH, Verhoef M. Components of an anticancer diet: dietary recommendations, restrictions and supplements of the Bill Henderson Protocol. Nutrients 2011;3:1-26. [PMID: 22254073 DOI: 10.3390/nu3010001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Pappas S, Krzywda E, Mcdowell N. Nutrition and Pancreaticoduodenectomy. Nutr Clin Pract 2010;25:234-43. [DOI: 10.1177/0884533610368709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
42 Brownlee IA, Forster DJ, Wilcox MD, Dettmar PW, Seal CJ, Pearson JP. Physiological parameters governing the action of pancreatic lipase. Nutr Res Rev 2010;23:146-54. [PMID: 20193096 DOI: 10.1017/S0954422410000028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
43 Kreindler JL. Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies. Pharmacol Ther 2010;125:219-29. [PMID: 19903491 DOI: 10.1016/j.pharmthera.2009.10.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
44 Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros. 2009;8:370-377. [PMID: 19815466 DOI: 10.1016/j.jcf.2009.08.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
45 Christiansen SR, Broniscer A, Panetta JC, Stewart CF. Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature. Pharmacotherapy 2009;29:858-66. [PMID: 19558260 DOI: 10.1592/phco.29.7.858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
46 Krishnamurty DM, Rabiee A, Jagannath SB, Andersen DK. Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis. Ther Clin Risk Manag 2009;5:507-20. [PMID: 19707261 DOI: 10.2147/tcrm.s3196] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
47 Naikwade SR, Meshram RN, Bajaj AN. Preparation and In Vivo Efficacy Study of Pancreatin Microparticles as an Enzyme Replacement Therapy for Pancreatitis. Drug Development and Industrial Pharmacy 2009;35:417-32. [DOI: 10.1080/03639040802422104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
48 Keller BO, Davidson AG, Innis SM. Phthalate metabolites in urine of CF patients are associated with use of enteric-coated pancreatic enzymes. Environ Toxicol Pharmacol. 2009;27:424-427. [PMID: 21783974 DOI: 10.1016/j.etap.2008.12.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
49 Williams NT. Medication administration through enteral feeding tubes. American Journal of Health-System Pharmacy 2008;65:2347-57. [DOI: 10.2146/ajhp080155] [Cited by in Crossref: 122] [Cited by in F6Publishing: 97] [Article Influence: 8.7] [Reference Citation Analysis]
50 Khan AZ, Ching R, Morris-Stiff G, England R, Sherridan MB, Smith AM. Pleuropancreatic fistulae: specialist center management. J Gastrointest Surg. 2009;13:354-358. [PMID: 18972169 DOI: 10.1007/s11605-008-0699-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
51 Park J, Cho S, Choi S. Purification and characterization of hepatic lipase from Todarodes pacificus. BMB Reports 2008;41:254-8. [DOI: 10.5483/bmbrep.2008.41.3.254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
52 Nakakura EK, Warren RS. Palliative care for patients with advanced pancreatic and biliary cancers. Surg Oncol. 2007;16:293-297. [PMID: 17855076 DOI: 10.1016/j.suronc.2007.08.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]